Pulmonary Function Testing Systems Market: by Type (Complete PFT Systems, Portable PFT Systems, and Others), Test Type (Spirometry, Lung Volume, Gas Exchange Testing, and Others), Component (Software, Hardware, Service, and Others), Application (Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and Others), End-user (Hospital/Clinical Laboratories, Diagnostics Laboratories, and Others), and Geography  

Pulmonary Function Testing Systems Market size was valued at USD 138.4 million in 2022 and is poised to grow at a CAGR of 4.4% from 2023 to 2029. The increase in the prevalence of respiratory diseases such as COPD, asthma, and other chronic lung diseases all over the world. Additionally, increasing consumption of tobacco products, increase in air pollution, rising demand for minimally invasive tests for treatment and diagnosis, increase in the awareness regarding the respiratory function testing systems, and advanced healthcare systems in developed countries are expected to enhance the sales of the market. Pulmonary function testing (PFT) refers to the use of instruments to detect pulmonary impairment and respiratory problems. Because of rising cigarette usage, climate change, and increased air pollution, disorders related to breathing have become more prevalent. The rate of flow, lung volume capacity, and gas exchange are all measured with these systems. The systems aid in the diagnosis of lung illnesses as well as the selection of treatment or medicines.